Biocytogen

🔓 Unlock the Future of Drug Discovery at Gene-ius Break Maryland Forum! 🚀 Join us for Gene-ius Break Biotech/Biopharma Forum in Maryland, where you can engage in lively discussions on early-stage drug discovery and FDA approval regulations on the panels. This is a unique opportunity to engage in lively discussions and network with industry experts. Plus, enjoy complimentary food and drinks while expanding your professional connections. 🗓️ Date: Wednesday, October 23rd · 4:30pm - 8pm EST 📍 Location: Greencourt Innovation Center. 12358 Parklawn Dr. North Bethesda, MD 20852 RSVP now: https://lnkd.in/ggCc3gDh #BiotechEvent #BiopharmaForum #DrugDiscovery #FDARegulations #Networking #Biocytogen #HealthcareLeadership #MarylandEvents

🔍 Breaking the Diabesity Cycle: Unveiling New Research on Obesity & Diabetes Obesity and diabetes are deeply intertwined, impacting millions worldwide—with severe obesity raising the risk of Type 2 diabetes by up to 20 times! 🐭 To tackle these challenges, Biocytogen has developed specialized animal models that replicate human conditions and accelerate drug development targeting promising pathways. Here are some examples of our featured models: - DIO Mouse Model: Models obesity via a high-fat diet, supporting studies on insulin resistance and Type 2 diabetes. - Drug-Targeted Humanized GLP1R Mice: Carries the human GLP1R gene, ideal for in vivo evaluation of GLP1R-targeting drugs. - B-ob/ob Mice: Investigates hyperglycemia and obesity by knocking out exons 2 and 3 of the leptin gene. - STZ-Induced Diabetes Model: Mimics Type 1 diabetes by selectively reducing insulin-producing cells. Interested in advancing your obesity and diabetes research? Contact us today to learn more! 💡 Read more: https://lnkd.in/eJFXwDtc #Diabesity #ObesityResearch #DiabetesResearch #AnimalModels #Biocytogen #Type2Diabetes #DrugDiscovery #Biotech #Pharma

I’m excited to invite you to the Maryland Forum! Join us for insightful discussions and networking with industry leaders and high quality free food and drinks. 📅 Date: October 23rd, Wednesday 📍 Location: Greencourt Innovation Center, 12358 Parklawn Dr, Rockville, MD 20852 🕒 Time: 4:30-8:00PM Featured Speakers/Panelists: Dr. Dallas Flies, VP of Nextcure Dr. Zhenzhen Liu, Senior Director of Regeneron Dr. Chaohong Fan, US Board Certified Oncologist and Hematologist Dr. Zhihong Li, Former FDA Senior Reviewer Dr. James Jin, VP of Biocytogen Register here: https://lnkd.in/g5-ta7ZM Don’t miss out on this fantastic opportunity to connect and learn! Looking forward to seeing you there!

🔬 Biocytogen’s Advanced Neurobehavioral Testing Platform 🔬 Genetic rodent models are crucial for offering insights into the behavior, pathology, and potential CNS therapies for neurobehavioral disorders. At Biocytogen, we provide a comprehensive portfolio of genetically humanized mouse models and advanced CNS disease models, along with a cutting-edge neurobehavioral testing platform to evaluate phenotypes across key functions, including anxiety, cognition, learning, memory, movement, perception, and more. Innovate the future of neurobehavioral research with us!🚀 #NeuroScience #Biocytogen #CNSResearch #NeurobehavioralTesting #Pharmacology #BiotechInnovations #ResearchAdvances #GeneticModels #InnovationInScience

Unlocking the Future of Weight Loss: GIP/GIPR Antibodies 💡💪 With GLP-1 receptor agonists dominating the weight loss market, new approaches are needed to tackle challenges like weight regain, muscle loss, and side effects. Eli Lilly’s tirzepatide, a GLP-1/GIP dual agonist, shows promising results in weight loss and liver health, highlighting the GIP/GIPR pathway’s potential in obesity and diabetes therapy. Biocytogen is advancing the field with fully human GIP/GIPR antibodies, developed through our RenMice® platform. These assets are ideal for creating bispecific antibodies and combination therapies targeting obesity and diabetes. 🔬🧬 With a library of over 400,000 human antibodies across 1,000 disease targets, Biocytogen is ready to collaborate on evaluation, licensing, or co-development. Let’s work together to bring the next generation of weight loss therapies to life! #WeightLossInnovation #Biocytogen #GIPGIPR #RenMice #Biotech #PharmaCollaboration #ObesityResearch #DiabetesTherapy

🚀 Join us on Oct 23 at 11:00 AM EST for Biocytogen’s webinar, “Exploring Fully Human Nanobodies for Innovative Disease Treatments,” with Dr. Yongfei Yang. Learn how our RenNano and Beacon platforms are advancing nanobody development for breakthrough therapies! #Nanobodies #Biocytogen #Webinar #InnovativeTherapies #Biotech

⏰ TOMORROW: Gene-ius Break in Basel! ⏰ Don't miss your chance to join Biocytogen’s Gene-ius Break on Oct 16th! Enjoy a fun-filled happy hour with complimentary food, drinks, and plenty of networking with top biotech professionals. Spots are filling fast, register now to secure your place!

We're live at FOB Basel! Swing by at booth #700 and connect with us. 😊

We’re enjoying beautiful weather this weekend! It’s been a pleasure attending the Science Symposium hosted by the Chinese Biopharmaceutical Association in Rockville, MD, where we explored cutting-edge research and strategies in weight management. Exciting news—Biocytogen has just released new data using humanized mice and the DIO model! Mark your calendars for #October23rd as Biocytogen will be hosting Biopharma/Biotech Science Forum in Maryland, featuring experts from Biopharma/Biotech as speakers and regulatory professionals as panelists. Stay tuned!

🌟 Basel! Gene-ius Break is Just Next Week! 🌟 Join top biotech professionals for an evening of networking, innovation, and complimentary food and drinks. Don’t miss this chance to connect with industry leaders in a relaxed setting—reserve your spot today! #Biocytogen #GeneiusBreak #Basel #Networking #Biotech #Innovation